Roadmaps to the Intertwined IP and Regulatory Regimes in China
May 13, 2020 9:00 AM to 10:00 AM
Virtual - all times are eastern daylight time
60 Minutes of MCLE
Moderator: Jeremy K. McKown, Janssen R&D, New Brunswick, NJ
TopicsDevelopments in pharmaceutical IP and regulatory coordination efforts to stimulate faster and better pharmaceutical development in China
Juhua Luo, CCPIT Patent and Trademark Law Office, Beijing, China
Using Patent Law and Policy for Incentivizing Green Technology Innovation in China
Wen Cao, Principal of Shanghai Office of NTD, Shanghai, China
Presented by the IP Practice in China Committee and the US Group of AIPPI
CCPIT Patent and Trademark Law OfficeMr. Luo's practice focuses mainly on prosecution of patent.
McKown, Jeremy K.
Janssen R&D at Johnson & Johnson | Vice President of LawJeremy is a Vice-President at Janssen R&D, a Johnson & Johnson affiliate (J&J), where he manages a global team of attorneys and professionals focused on drafting and negotiating complex agreements related to J&J's pharmaceutical business.
Shanghai Office of NTD | Senior PartnerMs. Cao serves as the principal of NTD Shanghai Office.